{
    "organizations": [],
    "uuid": "eb9454d00d505dcc65dde05b26c9bc9b11a57cd8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biomerieux-q1-sales-up-34-percent/brief-biomerieux-q1-sales-up-3-4-percent-587-million-euros-idUSFWN1RV0Z8",
    "ord_in_thread": 0,
    "title": "BRIEF-Biomerieux Q1 Sales Up 3.4 Percent 587 Million Euros",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - BIOMERIEUX SA:\n* Q1 SALES EUR 587 MILLION UP 3.4 PERCENT YOY * NET DEBT AMOUNTED TO EUR 84 MILLION AT MARCH 31, 2018, VERSUS EUR 156 MILLION AT DECEMBER 31, 2017\n* SALES OF CLINICAL APPLICATIONS ROSE BY 13.5% YEAR-ON-YEAR TO EUR 486 MILLION FOR Q1 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-19T13:06:00.000+03:00",
    "crawled": "2018-04-20T11:33:31.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "biomerieux",
        "sa",
        "q1",
        "sale",
        "eur",
        "million",
        "percent",
        "yoy",
        "net",
        "debt",
        "amounted",
        "eur",
        "million",
        "march",
        "versus",
        "eur",
        "million",
        "december",
        "sale",
        "clinical",
        "application",
        "rose",
        "eur",
        "million",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}